De Strooper, Lise M A <br/><br/>
Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.  [electronic resource] 

 -  International journal of cancer  09 2018 
 - 1541-1548 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.31539  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--diagnosis<br/>Adult<br/>Biomarkers, Tumor--genetics<br/>Carcinoma, Squamous Cell--diagnosis<br/>Case-Control Studies<br/>Cohort Studies<br/>Cytokines--genetics<br/>DNA Methylation<br/>Early Detection of Cancer<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Human papillomavirus 16--genetics<br/>Human papillomavirus 18--genetics<br/>Humans<br/>MicroRNAs--genetics<br/>Middle Aged<br/>Netherlands<br/>Papillomavirus Infections--complications<br/>Prognosis<br/>Risk Factors<br/>Survival Rate<br/>Time Factors<br/>Uterine Cervical Neoplasms--diagnosis<br/>Vaginal Smears<br/>Uterine Cervical Dysplasia--diagnosis